Guest Author – Namrata Saxena, Technical Specialist – Phenomenex Asia/Pacific Monoclonal Antibodies are large and complex biomolecules which falls in the prominent section of biotherapeutic drugs market. The complex structure Continue Reading
Powerful Analytical Solutions for Biotherapeutics Development and QC
A transformation in the pharmaceutical industry has occurred in the past few decades due to the advancement of biologics as therapeutic agents. What is less often discussed is a similar Continue Reading
Protein Therapeutics and the Best Methods to Analyze Them
Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager What are protein therapeutics / monoclonal antibodies? Protein therapeutics, specifically monoclonal antibodies (mAbs), have emerged as the most marketed biologic drug Continue Reading
Is Your LC Column for Biologics Analysis, Truly Bio-Inert?
Let’s talk about column priming and how to address this common concern Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager With the emerging trend of biotherapeutics in the pharmaceutical industry, Continue Reading
Doing HPLC Method Development for Monoclonal Antibody Aggregates? Wait a “SEC”!
By Guest Author: Brian Rivera Contrary to popular belief, size exclusion chromatography (SEC) isn’t straightforward. However, it should be—it’s a non-absorptive separation, right? Just look up an SEC column’s calibration Continue Reading
ADCs-Magic Bullets, Failed Drugs, and Heterobifunctional Linkers
Guest Author: Brian Rivera, Product Manager: Bio Separations Over a hundred years ago, Nobel Prize laureate, Paul Ehrlich, envisioned a drug which could kill microbes but not harm the body, Continue Reading